CAP TODAY/Biocept Webinar: A new CSF assay can improve detection and management of brain metastases

Thank you

This live web event has ended. Thank you for attending.

Description

A new CSF assay can improve detection and management of brain metastases

Why should you register now for this webinar?
Hear leading experts discuss how a new CSF assay can improve detection
and management of brain metastases
Brought to you by: CAP TODAY
Moderated by: Bob McGonnagle, Publisher, CAP TODAY
Presenters: Michael C. Dugan, MD, Seema Nagpal, MD, and Santosh Kesari, MD, PhD

What will this webinar empower you to do?

Understand the potential of enhanced CSF tumor cell and tumor DNA detection
Distinguish characteristics of new “liquid biopsy” sample types such as CSF
Appreciate the therapeutic response monitoring potential of CSF
Ask questions of our distinguished presenters

CAP TODAY does not endorse any of the products or services named within. The webinar is made possible by a special educational grant from Biocept.

Contributors

Michael C. Dugan, MD

Senior Vice President, Chief Medical Officer and Medical Director
Biocept
San Diego, CA
Seema Nagpal, MD

Seema Nagpal, MD
Clinical Associate Professor of Neurology
Division of Neuro-oncology
Stanford University
Santosh Kesari, MD, PhD

Professor of Neurosciences, Chair of the Department of Translational Neurosciences, Director of Neuro-Oncology Saint John’s Cancer Institute
Santa Monica, CA
Bob McGonnagle

Publisher, CAP TODAY